0

Testosterone Replacement Therapy Market by Product and Geography - Forecast and Analysis 2020-2024

  • Published: Oct 2020
  • Pages: 120
  • SKU: IRTNTR45364
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single User:

    Quick and easy buy and download option

  • Enterprise:

    Flexible option - Complimentary customization included

2500 USD

The testosterone replacement therapy market size has the potential to grow by USD 113.54 million during 2020-2024, and the market's growth momentum will decelerate during the forecast period.

This report provides a detailed analysis of the market by product (injectables, topicals, and others) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market's competitive landscape and offers information on several market vendors, including AbbVie Inc., Acerus Pharmaceuticals Corp., Antares Pharma Inc., Bayer AG, Clarus Therapeutics Inc., Eli Lilly and Co., Endo International Plc, Ferring Pharmaceuticals AS, Novartis AG, and Pfizer Inc.

Market Overview

Testosterone Replacement Therapy Market Size

Browse TOC and LoE with selected illustrations and example pages of Testosterone Replacement Therapy Market

Request a FREE sample now!

Market Competitive Analysis

The testosterone replacement therapy market is fragmented. Key vendors hold significant shares in the market. Established vendors have strong financial abilities and technical expertise in offering safer and effective products. The established vendors are deploying a significant share of their capitals in product R&D and are focusing on adopting organic growth strategies such as product launches to bring considerable differentiation in their products and gain higher customer penetration. The small-scale vendors are competing with the established vendors by using low price strategies and strengthening their local customer base. AbbVie Inc., Acerus Pharmaceuticals Corp., and Antares Pharma Inc. are some of the major market participants. Although the high prevalence of testosterone deficiency will offer immense growth opportunities, the adverse effects of testosterone replacement therapy will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

To help clients improve their market position, this testosterone replacement therapy market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market's competitive landscape and offers information on the products offered by various companies. Moreover, this testosterone replacement therapy market analysis report also provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.

This report provides information on the production, sustainability, and prospects of several leading companies, including:

  • AbbVie Inc.
  • Acerus Pharmaceuticals Corp.
  • Antares Pharma Inc.
  • Bayer AG
  • Clarus Therapeutics Inc.
  • Eli Lilly and Co.
  • Endo International Plc
  • Ferring Pharmaceuticals AS
  • Novartis AG
  • Pfizer Inc.

Testosterone Replacement Therapy Market: Segmentation by Geography

Testosterone Replacement Therapy Market Market segmentation by region

For more insights on the market share of various regions Request for a FREE sample now!

North America was the largest testosterone replacement therapy market in 2019, and the region will offer several growth opportunities to market vendors during the forecast period.  The increasing cases of hypogonadism and raising awareness about the treatment of testosterone deficiency and erectile dysfunction will significantly drive testosterone replacement therapy market growth in this region over the forecast period.

53% of the market's growth will originate from North America during the forecast period. The US is a key market for testosterone replacement therapy in North America. However, market growth in this region will be slower than the growth of the market in Asia and Europe.

Testosterone Replacement Therapy Market: Segmentation by Product

Testosterone Replacement Therapy Market Segmentation

Request for a FREE sample and Get more information on the market contribution of various segments

The injectables segment is witnessing a steady growth, owing to the availability of patient assistance programs and direct administration benefits. Another major factor associated with the growth of this market is the increase in the prevalence of testosterone deficiency. Major factors associated with the growth of the market also include low cost of treatment and convenience of infrequent dosing. 

Market growth in this segment will be faster than the growth of the market in the topicals and other segments. This report provides an accurate prediction of the contribution of all the segments to the growth of the testosterone replacement therapy market size.

Testosterone Replacement Therapy Market: Key Drivers and Trends

The prevalence of testosterone deficiency is increasing significantly across the world. The decrease in the release of testosterone results in the development of hypogonadism in men. The high prevalence of hypogonadism can be attributed to the increasing geriatric population and improved life expectancy. Another factor for the increasing prevalence of hypogonadism is related to the social stigma associated with hypogonadism among young men. Early intervention improves the chances of successful treatments for hypogonadism. The high prevalence of testosterone deficiency will be one of the major factors that will impact the testosterone replacement therapy market during the forecast period.

The rise in novel therapeutic approaches is one of the major testosterone replacement therapy (TRT) market trends that will impact growth in the coming years. The market has witnessed an increase in novel therapeutic approaches for treating lower testosterone deficiency. Researchers have already analyzed the therapeutics effects of Anakinra on testosterone levels of individuals with metabolic syndrome. As per the results, testosterone levels rose by 11% in the treatment group with the use of anti-inflammatory drugs. Such therapies will have a considerable impact on the growth of the testosterone replacement therapy market during the forecast period.

Event-Tickets-Market-Report

Request for a FREE sample

Testosterone Replacement Therapy Market: Key Highlights of the Report for 2020-2024

  • CAGR of the market during the forecast period 2020-2024
  • Detailed information on factors that will drive testosterone replacement therapy market growth during the next five years
  • Precise estimation of the testosterone replacement therapy market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the testosterone replacement therapy industry across Asia, Europe, North America, and ROW
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of testosterone replacement therapy market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Executive Summary

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Fiver forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Injectables - Market size and forecast 2019-2024
  • Topicals - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by Product

Customer Landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption
  • Competitive scenario

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • Acerus Pharmaceuticals Corp.
  • Antares Pharma Inc.
  • Bayer AG
  • Clarus Therapeutics Inc.
  • Eli Lilly and Co.
  • Endo International Plc
  • Ferring Pharmaceuticals AS
  • Novartis AG
  • Pfizer Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
Testosterone Replacement Therapy market growth will increase by $113.54 million during 2019-2024.
The testosterone replacement therapy market is expected to grow at a CAGR of 0.85% during 2019-2024.
Technavio has segmented the testosterone replacement therapy market by product (Injectables, Topicals, and Others) and geographic (North America, Europe, Asia, and ROW).
AbbVie Inc., Acerus Pharmaceuticals Corp., Antares Pharma Inc., Bayer AG, Clarus Therapeutics Inc., Eli Lilly and Co., Endo International Plc, Ferring Pharmaceuticals AS, Novartis AG, Pfizer Inc. are a few of the key vendors in the testosterone replacement therapy market.
North America will register the highest growth rate of 53.11% among the other regions. Therefore, the testosterone replacement therapy market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
The key factors driving the testosterone replacement therapy market growth are:
  • Initiatives to increase awareness on disease among population
The testosterone replacement therapy market vendors should focus on grabbing business opportunities from the segment as it accounted for the largest market share in the base year.
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted
Technavio

info
close
  • Single User:

    Quick and easy buy and download option

  • Enterprise:

    Flexible option - Complimentary customization included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Technavio
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>